Literature DB >> 20462723

AmpC beta-lactamases in Escherichia coli: emergence of CMY-2-producing virulent phylogroup D isolates belonging mainly to STs 57, 115, 354, 393, and 420, and phylogroup B2 isolates belonging to the international clone O25b-ST131.

Jesús Oteo1, Emilia Cercenado, Oscar Cuevas, Verónica Bautista, Alberto Delgado-Iribarren, Beatriz Orden, María Pérez-Vázquez, Silvia García-Cobos, José Campos.   

Abstract

Cephalosporins resistance is increasing in Escherichia coli in Spain. We characterize infections by E. coli with reduced susceptibility to third-generation cephalosporins (3GCs) with the AmpC phenotype. Between January 2004 and March 2007, 121 E. coli isolates with the AmpC phenotype were collected (4.8% of all the 2538 E. coli isolates with reduced susceptibility to 3GCs). These isolates were further characterized by clinical and molecular analysis. Plasmid-encoded ampC genes were detected in 46 (38%) isolates (43 CMY-2); 75 isolates (62%) had modifications in the chromosomal ampC promoter region (c-AmpC). CMY-2 producers belonged primarily to the more virulent phylogroup D (48.4%), whereas most isolates of c-AmpC belonged to phylogroup A (56.4%). Bacteremia and infections in children were more frequently produced by CMY-2 producers. CMY-2-producing phylogroup D E. coli belonged to 8 multilocus sequence typing types. Three CMY-2 producers belonged to O25b/ST131/B2 clone. Infections caused by E. coli with the AmpC phenotype may be spreading primarily because of CMY-2-producing phylogroup D isolates, although this enzyme was also detected in the O25b/ST131/B2 clone.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20462723     DOI: 10.1016/j.diagmicrobio.2010.02.008

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  13 in total

1.  Prevalence and molecular epidemiology of acquired AmpC β-lactamases and carbapenemases in Enterobacteriaceae isolates from 35 hospitals in Spain.

Authors:  E Miró; J Agüero; M N Larrosa; A Fernández; M C Conejo; G Bou; J J González-López; N Lara; L Martínez-Martínez; A Oliver; B Aracil; J Oteo; A Pascual; J Rodríguez-Baño; L Zamorano; F Navarro
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-09-07       Impact factor: 3.267

2.  Global Extraintestinal Pathogenic Escherichia coli (ExPEC) Lineages.

Authors:  Amee R Manges; Hyun Min Geum; Alice Guo; Thaddeus J Edens; Chad D Fibke; Johann D D Pitout
Journal:  Clin Microbiol Rev       Date:  2019-06-12       Impact factor: 26.132

3.  Genotypic-phenotypic discrepancies between antibiotic resistance characteristics of Escherichia coli isolates from calves in management settings with high and low antibiotic use.

Authors:  Margaret A Davis; Thomas E Besser; Lisa H Orfe; Katherine N K Baker; Amelia S Lanier; Shira L Broschat; Daniel New; Douglas R Call
Journal:  Appl Environ Microbiol       Date:  2011-03-18       Impact factor: 4.792

4.  Spanish multicenter study of the epidemiology and mechanisms of amoxicillin-clavulanate resistance in Escherichia coli.

Authors:  Adriana Ortega; Jesús Oteo; Maitane Aranzamendi-Zaldumbide; Rosa M Bartolomé; Germán Bou; Emilia Cercenado; M Carmen Conejo; Juan José González-López; Mercedes Marín; Luis Martínez-Martínez; María Merino; Ferran Navarro; Antonio Oliver; Alvaro Pascual; Alba Rivera; Jesús Rodríguez-Baño; Irene Weber; Belén Aracil; José Campos
Journal:  Antimicrob Agents Chemother       Date:  2012-04-09       Impact factor: 5.191

5.  Molecular Characterization and Antibiotic Susceptibility Profile of Acinetobacter baumannii Recovered from Hospital Wastewater Effluents.

Authors:  Qaqamba Mapipa; Tennison Onoriode Digban; Nonso Emmanuel Nnolim; Nolonwabo Nontongana; Anthony Ifeanyi Okoh; Uchechukwu U Nwodo
Journal:  Curr Microbiol       Date:  2022-03-08       Impact factor: 2.188

6.  Bloodstream infections caused by Escherichia coli producing AmpC β-lactamases: epidemiology and clinical features.

Authors:  V Pascual; N Alonso; M Simó; G Ortiz; M C Garcia; M Xercavins; A Rivera; M A Morera; E Miró; E Espejo; F Navarro; M Gurguí; J Pérez; M Rodríguez-Carballeira; J Garau; E Calbo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-08-22       Impact factor: 3.267

7.  Multidrug-resistant Escherichia coli from canine urinary tract infections tend to have commensal phylotypes, lower prevalence of virulence determinants and ampC-replicons.

Authors:  Samuel Wagner; David L Gally; Sally A Argyle
Journal:  Vet Microbiol       Date:  2014-01-13       Impact factor: 3.293

Review 8.  Epidemic potential of Escherichia coli ST131 and Klebsiella pneumoniae ST258: a systematic review and meta-analysis.

Authors:  M J D Dautzenberg; M R Haverkate; M J M Bonten; M C J Bootsma
Journal:  BMJ Open       Date:  2016-03-17       Impact factor: 2.692

9.  MALDI-TOF Mass Spectrometry for Multilocus Sequence Typing of Escherichia coli Reveals Diversity among Isolates Carrying blaCMY₋₂-Like Genes.

Authors:  Kaitlin A Tagg; Andrew N Ginn; Sally R Partridge; Jonathan R Iredell
Journal:  PLoS One       Date:  2015-11-20       Impact factor: 3.240

Review 10.  Escherichia coli β-Lactamases: What Really Matters.

Authors:  Priyanka Bajaj; Nambram S Singh; Jugsharan S Virdi
Journal:  Front Microbiol       Date:  2016-03-30       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.